Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine as a therapeutic agent.

R Mosqueda-Garcia1

  • 1Department of Medicine, School of Medicine, Vanderbilt University, Nashville, Tennessee.

Clinical and Investigative Medicine. Medecine Clinique Et Experimentale
|October 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sequential modulation of cardiac autonomic control induced by cardiopulmonary and arterial baroreflex mechanisms.

Circulation·2001
Same author

Oscillatory patterns in sympathetic neural discharge and cardiovascular variables during orthostatic stimulus.

Circulation·2000
Same author

The elusive pathophysiology of neurally mediated syncope.

Circulation·2000
Same author

Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance.

Circulation·1999
Same author

Neurally mediated syncope: pathophysiology and implications for treatment.

The American journal of the medical sciences·1999
Same author

Yohimbine in neurally mediated syncope. Pathophysiological implications.

The Journal of clinical investigation·1998
Same journal

Newsletter Spring 2026: Clinician Investigator Trainee Association of Canada (CITAC).

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

A study of suicide risk and prognostic characteristics in patients with osteosarcoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

The expression and mechanism of action of MicroRNA-210 in preeclampsia.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Risk assessment of intra-operative hemodynamic instability in patients with pheochromocytoma.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Development and validation of a deep vein thrombosis risk nomogram for post-operative complications in prostate cancer patients.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
Same journal

Analysis of the impact of SARS-CoV-2 infection on immune function and metabolic changes in college students.

Clinical and investigative medicine. Medecine clinique et experimentale·2026
See all related articles

Adenosine is highly effective for treating paroxysmal supraventricular tachycardia by targeting the atrioventricular node. It also shows efficacy in specific ventricular tachycardias, with common side effects including flushing and dyspnea.

Area of Science:

  • Cardiology
  • Pharmacology
  • Electrophysiology

Background:

  • Adenosine, an endogenous nucleoside, is a newly approved treatment for paroxysmal supraventricular tachycardia (PSVT).
  • It demonstrates near-complete efficacy in terminating tachycardias involving the atrioventricular node reentrant circuit.

Purpose of the Study:

  • To review the therapeutic applications and mechanisms of adenosine in cardiac arrhythmias.
  • To discuss adenosine's effectiveness in various tachycardia types, including catecholamine- or exercise-induced ventricular tachycardia.
  • To explore comparative trials, additional indications, and purinergic receptor involvement in adenosine's antiarrhythmic effects.

Main Methods:

  • Review of clinical trials and pharmacological data on adenosine.
  • Analysis of adenosine's efficacy in different supraventricular and ventricular tachycardias.

Related Experiment Videos

  • Examination of proposed mechanisms of action and receptor interactions.

    • Main Results:

    • Adenosine is nearly 100% effective for PSVT involving the atrioventricular node.
    • It is effective for specific ventricular tachycardias, such as those induced by catecholamines or exercise.
    • Common side effects include dyspnea, chest pressure, and facial flushing; standard dosing is 6 mg IV bolus, potentially followed by 12 mg.

    Conclusions:

    • Adenosine is a valuable therapeutic agent for specific cardiac arrhythmias, particularly PSVT.
    • Understanding its mechanisms and receptor interactions is crucial for optimizing its clinical use.
    • Further research and comparative trials are essential to fully elucidate its role in managing cardiac tachycardias.